Department of Medicine, Christiana Care Health System, Newark, New Jersey, USA.
Am J Perinatol. 2012 Apr;29(4):289-94. doi: 10.1055/s-0031-1295660. Epub 2011 Dec 6.
Due to disproportionately high mortality from 2009 H1N1 influenza, pregnant women were given highest priority for H1N1 vaccination. We surveyed postpartum women to determine vaccine uptake and reasons for lack of vaccination. We performed a cross-sectional survey of postpartum women delivering at our institution from February 1 to April 15, 2010. The 12-question survey ascertained maternal characteristics and vaccination concerns. Among 307 postpartum women, 191 (62%) had received H1N1 vaccination and 98 (32%) had declined. Factors associated with H1N1 vaccination included older age (relative risk [RR] 1.3, 95% confidence interval [CI] 1.1 to 1.5 for age ≥35 years compared with 20 to 34 years), at least college education (RR 1.5, 95% CI 1.3 to 1.8), prior influenza vaccination (RR 1.6, 95% CI 1.3 to 2.0), provider recommendation (RR 3.9, 95% CI 2.1 to 7.4), vaccination of family members (RR 1.6, 95% CI 1.3 to 1.9), and receipt of seasonal influenza vaccination (RR 2.2, 95% CI 1.7 to 2.9). Non-Hispanic black women were less likely to have been vaccinated (RR 0.6, 95% CI 0.5 to 0.8) than non-Hispanic white women. Safety concerns were cited by the majority (66%) of nonvaccinated women. H1N1 vaccine uptake among pregnant women was substantially higher than reported influenza vaccination rates during previous seasons. Safety concerns were the major barrier to vaccination.
由于 2009 年 H1N1 流感导致的死亡率异常高,孕妇被列为 H1N1 疫苗接种的最高优先级人群。我们调查了产后妇女,以确定疫苗接种率和未接种疫苗的原因。我们对 2010 年 2 月 1 日至 4 月 15 日在我们机构分娩的产后妇女进行了横断面调查。该 12 个问题的调查确定了产妇的特征和疫苗接种关注点。在 307 名产后妇女中,有 191 人(62%)接种了 H1N1 疫苗,98 人(32%)拒绝接种。与接种 H1N1 疫苗相关的因素包括年龄较大(年龄≥35 岁与 20 至 34 岁相比,相对风险 [RR] 1.3,95%置信区间 [CI] 1.1 至 1.5)、至少受过大学教育(RR 1.5,95%CI 1.3 至 1.8)、既往流感疫苗接种(RR 1.6,95%CI 1.3 至 2.0)、提供者推荐(RR 3.9,95%CI 2.1 至 7.4)、家庭成员接种疫苗(RR 1.6,95%CI 1.3 至 1.9)和季节性流感疫苗接种(RR 2.2,95%CI 1.7 至 2.9)。与非西班牙裔白人妇女相比,非西班牙裔黑人妇女接种疫苗的可能性较低(RR 0.6,95%CI 0.5 至 0.8)。大多数(66%)未接种疫苗的妇女提到了安全性问题。孕妇接种 H1N1 疫苗的比例明显高于以往季节报告的流感疫苗接种率。安全性问题是接种疫苗的主要障碍。